Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

4.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K
Disorders of Leukocytes01:27

Disorders of Leukocytes

2.3K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.3K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.2K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinician-documented Firearm Access and Safety Interventions for Veterans Receiving Suicide Risk Evaluation in VA Emergency Care Settings.

The western journal of emergency medicine·2026
Same author

Adverse Health Events in Chronic Myeloid Leukaemia Patients Treated With Tyrosine Kinase Inhibitors 2009-2019: A Real-World Study From the UK's Haematological Malignancy Research Network.

International journal of cancer·2026
Same author

The Limits of Averages: A Framework for Contextual Effectiveness in Palliative Care Medicinal Cannabis Research.

Cannabis and cannabinoid research·2026
Same author

Challenges with Tracking Post Concussive Symptoms Using the Neurobehavioral Symptom Inventory in Active Duty Service Members with Mild Traumatic Brain Injury.

Military medicine·2026
Same author

Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategies.

British journal of haematology·2026
Same author

Male sex adversely impacts survival and myeloid malignancy risk in MGUS: a real-world population-based study.

Haematologica·2026

Related Experiment Video

Updated: Mar 15, 2026

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

30.9K

Key Data Elements in Myeloid Leukemia.

Julian Varghese1, Christian Holz1, Phillip Neuhaus1

  • 1Institute of Medical Informatics, University of Muenster, Germany.

Studies in Health Technology and Informatics
|September 1, 2016
PubMed
Summary
This summary is machine-generated.

This study establishes common data elements (CDEs) for myeloid leukemia (ML) documentation, enhancing data standardization and analysis. An international expert review achieved high agreement, creating a foundation for global ML data standards.

More Related Videos

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.8K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

2.0K

Related Experiment Videos

Last Updated: Mar 15, 2026

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

30.9K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.8K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

2.0K

Area of Science:

  • Hematology
  • Medical Informatics
  • Data Standardization

Background:

  • Clinical documentation in myeloid leukemia (ML) lacks standardization across institutions, hindering efficient data management and scientific analysis.
  • Existing documentation models require harmonization to facilitate data sharing and research.
  • The development of common data elements (CDEs) is crucial for improving data quality and consistency in ML research.

Purpose of the Study:

  • To establish a semantic core of CDEs for routine and trial documentation in myeloid leukemia (ML).
  • To create language-independent semantic codes for CDEs through expert review and international consensus.
  • To lay the groundwork for an international data standard for ML.

Main Methods:

  • Automatic UMLS-based analysis of existing ML documentation models to identify potential CDEs.
  • Initial review and expert commentary on 227 identified CDEs by leukemia specialists.
  • International survey and voting process involving seven hematologists from four countries to achieve consensus on CDEs.

Main Results:

  • A core set of 227 CDEs was generated for ML documentation.
  • An overall agreement score of 86% was achieved across international hematologists.
  • 51% of the CDEs (116 elements) received 100% agreement, indicating strong consensus.
  • CDEs were developed with language-independent semantic codes and underwent international clinical expert review.

Conclusions:

  • The study successfully generated a consensus-driven list of CDEs for ML, forming a foundational approach to an international data standard.
  • The developed CDEs, with their language-independent codes and expert validation, are ready for implementation in various medical information systems.
  • This work represents a significant step towards harmonized data documentation and improved scientific data analysis in the field of myeloid leukemia globally.